Antitumor activity of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride in a variety of experimental tumors
- PMID: 710804
Item in Clipboard
Antitumor activity of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride in a variety of experimental tumors
Gan.
1978 Aug.
Abstract
A water-soluble nitrosourea, 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride (ACNU, NSC-245382), was tested for its antitumor activity against some kinds of transplantable mouse tumors. The compound was markedly active against myeloid leukemia C1498, plasmacytoma X5563, Ehrlich ascites carcinoma, and mammary tumor FM3A43, and moderately active against mammary tumor MM102 and meningeal sarcoma MS147. It appears that ACNU has a broad antitumor spectrum.
Similar articles
-
Effect of 1-(2-chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea on experimental tumors.Gan. 1982 Jun;73(3):480-7. Gan. 1982. PMID: 7129012
-
Antitumor activity and toxicity of methyl 6-[3-(2-chloroethyl)- 3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside in experimental animals.Gan. 1984 Oct;75(10):937-46. Gan. 1984. PMID: 6510639
-
Potentiation of therapeutic effects of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride by 6-thioguanine in mouse tumor systems: comparison with other antimetabolites.Gan. 1980 Feb;71(1):60-72. Gan. 1980. PMID: 6929770
-
[Enzyme therapy of neoplasms].Vestn Akad Med Nauk SSSR. 1971;26(11):35-46. Vestn Akad Med Nauk SSSR. 1971. PMID: 4330950 Review. Russian. No abstract available.
-
Nitrosoureas: a review of experimental antitumor activity.Cancer Treat Rep. 1976 Jun;60(6):665-98. Cancer Treat Rep. 1976. PMID: 782694 Review.
Cited by
-
Phase II study of ACNU in non-small-cell lung cancer: EORTC study 08872.Cancer Chemother Pharmacol. 1991;28(2):145-6. doi: 10.1007/BF00689706. Cancer Chemother Pharmacol. 1991. PMID: 1647894
-
Phase II trial of nimustine (ACNU; 3-[4-amino-2-methyl-5-pyrimidinyl) methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride) in patients with small cell carcinoma of the lung after failure on combination chemotherapy.Invest New Drugs. 1986;4(2):175-9. doi: 10.1007/BF00194599. Invest New Drugs. 1986. PMID: 3015827
-
CGP 6809, a sugar-containing nitrosourea derivative: pharmacological and physicochemical properties.Cancer Chemother Pharmacol. 1989;23(6):341-7. doi: 10.1007/BF00435833. Cancer Chemother Pharmacol. 1989. PMID: 2713956
-
Experimental and clinical effect of ACNU in Japan with emphasis on small-cell carcinoma of the lung.Cancer Chemother Pharmacol. 1980;4(3):165-71. doi: 10.1007/BF00254013. Cancer Chemother Pharmacol. 1980. PMID: 6249513
-
Phase II study of ACNU as second-line treatment in small-cell lung cancer. EORTC Lung Cancer Cooperative Group.Cancer Chemother Pharmacol. 1992;29(5):409-11. doi: 10.1007/BF00686013. Cancer Chemother Pharmacol. 1992. PMID: 1312909 Clinical Trial.